"
Template:SupbiotechparisFr
From 2009.igem.org
(Difference between revisions)
Enguerrand (Talk | contribs) |
Enguerrand (Talk | contribs) |
||
| Line 71: | Line 71: | ||
[[Team:SupBiotech-Paris/Ciblage Tissulaire#drapeau|Ciblage Tissulaire]] | [[Team:SupBiotech-Paris/Ciblage Tissulaire#drapeau|Ciblage Tissulaire]] | ||
[[Team:SupBiotech-Paris/Ciblage Cellulaire#drapeau|Action antitumorale]] | [[Team:SupBiotech-Paris/Ciblage Cellulaire#drapeau|Action antitumorale]] | ||
| - | Team:SupBiotech-Paris/Modeling du traitement#drapeau|Modeling du traitement]] | + | [[Team:SupBiotech-Paris/Modeling du traitement#drapeau|Modeling du traitement]] |
[[Team:SupBiotech-Paris/Conclusion3Fr#drapeau|Conclusion]] | [[Team:SupBiotech-Paris/Conclusion3Fr#drapeau|Conclusion]] | ||
Revision as of 16:43, 17 October 2009
Projet
Introduction Thérapies actuelles Thérapies géniques Le DVS Concept Vecteur Tissulaire Vecteur Cellulaire Plasmide thérapeutique Conclusion Mise en application Ciblage Tissulaire Action antitumorale Modeling du traitement Conclusion
Ressources
Biobricks Matériel & Méthode Bibliographie
Ethique & sûreté
